118 related articles for article (PubMed ID: 29453593)
1. Risk marker profiles in patients treated with percutaneous septal ablation for symptomatic hypertrophic obstructive cardiomyopathy.
Burghardt A; van Buuren F; Dimitriadis Z; Grübbel T; Seggewiss H; Scholtz S; Horstkotte D; Faber L
Clin Res Cardiol; 2018 Jun; 107(6):479-486. PubMed ID: 29453593
[TBL] [Abstract][Full Text] [Related]
2. Percutaneous intramyocardial septal radiofrequency ablation after 5-year follow-up.
Ta S; Li J; Hsi DH; Hu R; Lei C; Shan B; Li W; Wang J; Wang B; Kang N; Li X; Liu J; Qi C; Huang J; Han Y; Ruan F; Zhang J; Liu L
Heart; 2024 May; 110(11):792-799. PubMed ID: 38388470
[TBL] [Abstract][Full Text] [Related]
3. Transcoronary ablation of septal hypertrophy for hypertrophic obstructive cardiomyopathy: feasibility, clinical benefit, and short term results in elderly patients.
Gietzen FH; Leuner CJ; Obergassel L; Strunk-Mueller C; Kuhn H
Heart; 2004 Jun; 90(6):638-44. PubMed ID: 15145866
[TBL] [Abstract][Full Text] [Related]
4. Percutaneous approach for reducing outflow tract obstruction in hypertrophic obstructive cardiomyopathy.
Ojha U; Parikh M; Patel V
Future Cardiol; 2023 Mar; 19(4):203-210. PubMed ID: 37387205
[TBL] [Abstract][Full Text] [Related]
5. Comparison of Effectiveness of Alcohol Septal Ablation Versus Ventricular Septal Myectomy on Acute Care Use for Cardiovascular Disease in Patients With Hypertrophic Cardiomyopathy.
Shimada YJ; Goto T; Takayama H; Brown DFM; Homma S; Maurer MS; Reilly MP; Hasegawa K
Am J Cardiol; 2019 Oct; 124(8):1272-1278. PubMed ID: 31447010
[TBL] [Abstract][Full Text] [Related]
6. Alcohol septal ablation in patients aged 75 years or older with hypertrophic obstructive cardiomyopathy.
Lawin D; Stellbrink C; Stellbrink E; Buck B; Poudel MR; Tego A; Marx K; Lawrenz T
Heart; 2023 Nov; 109(23):1778-1784. PubMed ID: 37460195
[TBL] [Abstract][Full Text] [Related]
7. A case of percutaneous septal myocardial ablation in a patient with obstructive hypertrophic cardiomyopathy with accessory mitral valve tissue.
Eto H; Uzu K; Nagasawa Y; Shimokawa Y; Okubo H; Shimizu H
J Cardiol Cases; 2024 Jan; 29(1):39-42. PubMed ID: 38188315
[TBL] [Abstract][Full Text] [Related]
8. Percutaneous Septal Ablation in Hypertrophic Obstructive Cardiomyopathy: From Experiment to Standard of Care.
Faber L
Adv Med; 2014; 2014():464851. PubMed ID: 26556411
[TBL] [Abstract][Full Text] [Related]
9. Outcomes of concomitant surgical ablation in patients undergoing surgical myectomy for hypertrophic obstructive cardiomyopathy: A systematic review and meta-analysis.
Kharbanda RK; Ramdat Misier NL; Van den Eynde J; El Mathari S; Tomšič A; Palmen M; Klautz RJM
Int J Cardiol; 2023 Sep; 387():131099. PubMed ID: 37263356
[TBL] [Abstract][Full Text] [Related]
10. Short time effects of two radiofrequency ablation methods on hypertrophic obstructive cardiomyopathy.
He YG; Dong Y; Yang SH; Yang F; Yin JL; Zhao HQ; Zhao YJ
Clin Cardiol; 2024 Feb; 47(3):e24217. PubMed ID: 38439605
[TBL] [Abstract][Full Text] [Related]
11. Transapical intramyocardial septal microwave ablation in treatment of hypertrophic obstructive cardiomyopathy: 12-month outcomes of a swine model.
Zhou M; Li Z; Liu Y; Fang Y; Qin L; Yang W; Yan F; Zhao Q
J Cardiothorac Surg; 2024 Apr; 19(1):205. PubMed ID: 38615019
[TBL] [Abstract][Full Text] [Related]
12. Identifying Obstructive Hypertrophic Cardiomyopathy from Nonobstructive Hypertrophic Cardiomyopathy: Development and Validation of a Model Based on Electrocardiogram Features.
Guo L; Ma Z; Yang W; Zhang F; Shao H; Liu L; Gao C; Tao L
Glob Heart; 2023; 18(1):40. PubMed ID: 37547171
[TBL] [Abstract][Full Text] [Related]
13. Transcoronary radiofrequency ablation for obstructive hypertrophic cardiomyopathy: a feasibility study.
Long X; Deng S; Liu W; Bu J; Chen Y; Tan H; Zheng D; Yu S; Liang Q; Zhang C; Wu Q
Eur Heart J; 2024 Jan; 45(3):233-235. PubMed ID: 37936240
[No Abstract] [Full Text] [Related]
14. Myocardial perfusion improvement and mechanism after percutaneous intramyocardial septal radiofrequency ablation in obstructive hypertrophic cardiomyopathy: a study of myocardial contrast echocardiography.
Yao L; Ta S; Wang J; Han C; Lei C; Li W; Li J; Wang B; Zhao X; Liu L
Int J Cardiovasc Imaging; 2024 May; ():. PubMed ID: 38709352
[TBL] [Abstract][Full Text] [Related]
15. Predictive value of estimated plasma volume for postoperative hypotension in percutaneous intramyocardial septal radiofrequency ablation treating for hypertrophic obstructive cardiomyopathy.
Shan B; Li J; Shi Z; Han C; Zhang J; Zhao J; Hu R; Liu L; Ta S
BMC Cardiovasc Disord; 2024 Mar; 24(1):177. PubMed ID: 38519968
[TBL] [Abstract][Full Text] [Related]
16. When radiation meets the heart: Future of stereotactic body radiation therapy for hypertrophic obstructive cardiomyopathy.
Liao L; Tang H; Hu L; Zhou S; Li X
Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2023 Dec; 48(12):1914-1919. PubMed ID: 38448385
[TBL] [Abstract][Full Text] [Related]
17. Case Report: Integrated echocardiographic assessment guided Liwen procedure for treating obstructive hypertrophic cardiomyopathy with ventricular aneurysm.
Zhang R; Zhao F; Wang J; Qin Y; Wang T; Chu AA
Front Cardiovasc Med; 2023; 10():1278457. PubMed ID: 38028451
[TBL] [Abstract][Full Text] [Related]
18. Septal radioablation therapy for patients with hypertrophic obstructive cardiomyopathy: first-in-human study.
Li X; Zhu Z; Liu J; Gao Y; Xiao Y; Fang Z; Liu Q; Liu X; Hu C; Ma F; Zeng M; Liu Z; Hu L; Liu N; Xiang F; Hu X; Huang L; Zhou S
Eur Heart J Open; 2023 May; 3(3):oead052. PubMed ID: 37503357
[TBL] [Abstract][Full Text] [Related]
19. Symptomatic hypertrophic obstructive cardiomyopathy: semi-supine bicycle ergometry as a useful provocative manoeuvre to elicit latent gradient.
Dhar SK; Varadharajan V; Al-Mohammad A; Sandoval J; Grech ED
BMJ Case Rep; 2009; 2009():. PubMed ID: 21686484
[TBL] [Abstract][Full Text] [Related]
20. A Cadaveric Evaluation of Hypertrophic Obstructive Cardiomyopathy.
Murtha CM; Dobson JR; Olinger AB
Cureus; 2023 Jun; 15(6):e40870. PubMed ID: 37489192
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
